Stone Run Capital, LLC Bio Techne Corp Transaction History

Stone Run Capital, LLC

  • $269 Billion
  • Q3 2024

A detailed history of Stone Run Capital, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Stone Run Capital, LLC holds 76,765 shares of TECH stock, worth $5.78 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares
76,765
Previous 76,940 0.23%
Holding current value
$5.78 Million
Previous $5.51 Billion 11.3%
% of portfolio
2.28%
Previous 2.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$70.96 - $82.35 $12,417 - $14,411
-175 Reduced 0.23%
76,765 $6.14 Billion
Q2 2024

Aug 14, 2024
SELL
$62.12 - $84.15 $187,913 - $254,553
-3,025 Reduced 3.78%
76,940 $5.51 Billion
Q1 2024

May 14, 2024
SELL
$65.98 - $77.09 $112,166 - $131,053
-1,700 Reduced 2.08%
79,965 $5.63 Billion
Q4 2023

Feb 14, 2024
SELL
$52.83 - $78.22 $246,716 - $365,287
-4,670 Reduced 5.41%
81,665 $6.3 Billion
Q3 2023

Nov 14, 2023
BUY
$67.52 - $89.42 $5.83 Million - $7.72 Million
86,335 New
86,335 $5.88 Billion
Q2 2023

Aug 14, 2023
SELL
$73.76 - $85.98 $95,888 - $111,774
-1,300 Reduced 1.45%
88,135 $7.19 Million
Q1 2023

May 15, 2023
BUY
$71.62 - $86.62 $313,337 - $378,962
4,375 Added 5.14%
89,435 $6.64 Million
Q4 2022

Feb 14, 2023
BUY
$80.67 - $352.29 $5.08 Million - $22.2 Million
63,005 Added 285.67%
85,060 $7.05 Million
Q3 2022

Nov 14, 2022
SELL
$282.54 - $391.85 $98,889 - $137,147
-350 Reduced 1.56%
22,055 $6.26 Million
Q2 2022

Aug 15, 2022
BUY
$322.67 - $449.65 $25,813 - $35,972
80 Added 0.36%
22,405 $7.77 Million
Q1 2022

May 16, 2022
BUY
$353.85 - $487.79 $8,846 - $12,194
25 Added 0.11%
22,325 $9.67 Million
Q4 2021

Feb 14, 2022
SELL
$456.15 - $525.06 $273,690 - $315,035
-600 Reduced 2.62%
22,300 $11.5 Million
Q3 2021

Nov 15, 2021
SELL
$444.87 - $538.88 $1.47 Million - $1.78 Million
-3,300 Reduced 12.6%
22,900 $11.1 Million
Q2 2021

Aug 16, 2021
BUY
$387.35 - $450.26 $116,205 - $135,078
300 Added 1.16%
26,200 $11.8 Million
Q1 2021

May 17, 2021
SELL
$314.62 - $411.0 $456,199 - $595,950
-1,450 Reduced 5.3%
25,900 $9.89 Million
Q4 2020

Feb 16, 2021
SELL
$246.9 - $321.87 $262,948 - $342,791
-1,065 Reduced 3.75%
27,350 $8.69 Million
Q3 2020

Nov 13, 2020
BUY
$232.22 - $282.96 $17,416 - $21,222
75 Added 0.26%
28,415 $7.04 Million
Q2 2020

Aug 14, 2020
SELL
$185.43 - $279.56 $101,986 - $153,758
-550 Reduced 1.9%
28,340 $7.48 Million
Q1 2020

May 15, 2020
SELL
$161.17 - $221.51 $633,720 - $870,977
-3,932 Reduced 11.98%
28,890 $5.48 Million
Q4 2019

Feb 14, 2020
SELL
$189.68 - $222.09 $194,422 - $227,642
-1,025 Reduced 3.03%
32,822 $7.21 Million
Q3 2019

Nov 14, 2019
SELL
$183.56 - $216.72 $36,712 - $43,344
-200 Reduced 0.59%
33,847 $6.62 Million
Q2 2019

Aug 14, 2019
SELL
$188.72 - $215.43 $57,182 - $65,275
-303 Reduced 0.88%
34,047 $7.1 Million
Q1 2019

May 14, 2019
SELL
$136.09 - $200.44 $40,827 - $60,132
-300 Reduced 0.87%
34,350 $6.82 Million
Q4 2018

Feb 14, 2019
SELL
$132.75 - $203.8 $79,650 - $122,280
-600 Reduced 1.7%
34,650 $5.02 Million
Q3 2018

Nov 14, 2018
SELL
$147.44 - $204.11 $298,566 - $413,322
-2,025 Reduced 5.43%
35,250 $7.2 Million
Q2 2018

Aug 14, 2018
SELL
$144.9 - $165.58 $7,245 - $8,279
-50 Reduced 0.13%
37,275 $5.52 Million
Q1 2018

May 14, 2018
SELL
$131.46 - $151.04 $341,796 - $392,704
-2,600 Reduced 6.51%
37,325 $5.64 Million
Q4 2017

Feb 15, 2018
SELL
$121.17 - $134.75 $363,510 - $404,250
-3,000 Reduced 6.99%
39,925 $5.17 Million
Q3 2017

Nov 14, 2017
BUY
$113.59 - $123.78 $4.88 Million - $5.31 Million
42,925
42,925 $5.19 Million

Others Institutions Holding TECH

# of Institutions
603
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.95B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Stone Run Capital, LLC Portfolio

Follow Stone Run Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email